Anxiety and depression occur together so often that their overlap is more the rule than the exception. Among people who meet criteria for major depression, roughly half also have an anxiety disorder. In primary care settings, that number climbs above 75%. This isn’t a coincidence or a diagnostic quirk. The two conditions share genetic roots, overlapping brain chemistry, and common thinking patterns that make one condition fertile ground for the other.
They Share Most of the Same Genes
The strongest explanation for why anxiety and depression travel together is that they are, at the genetic level, largely the same condition expressed in different ways. Large-scale genetic studies have found that 99% of risk variants for anxiety also influence depression, and 73% of risk variants for depression also confer risk for anxiety. The overall genetic correlation between the two conditions falls between 80% and 95%, which is remarkably high.
When both conditions occur together, the genetic signal gets even stronger. The heritability of comorbid anxiety and depression is around 79%, compared to 41% for anxiety alone and 50% for depression alone. In other words, genetic factors explain substantially more variation in the combined presentation than in either condition by itself. This suggests that what we call “comorbid anxiety and depression” may actually be the core expression of a shared genetic vulnerability, with pure anxiety or pure depression representing incomplete versions of it.
A Shared Stress Response Gone Wrong
Your body has a built-in stress alarm system. When you encounter a threat, a chain reaction starts in the brain: the hypothalamus releases a signaling hormone, which triggers the pituitary gland, which tells the adrenal glands to pump out cortisol. Once cortisol levels get high enough, the system is supposed to shut itself off through a feedback loop. This is how healthy stress responses work: they fire up, handle the problem, and wind back down.
In both anxiety and depression, this shutdown mechanism breaks. Chronic stress disrupts the feedback loop, leaving cortisol levels persistently elevated. The result is a brain stuck in overdrive, unable to turn off its own alarm. This same malfunction, sustained cortisol production from a dysregulated stress axis, has been documented in major depression, generalized anxiety, and post-traumatic stress disorder. It’s not that anxiety causes the stress system to break in one way and depression in another. The underlying disruption is the same.
Brain imaging research adds another layer. The connection between the amygdala (which processes threat and fear) and the prefrontal cortex (which regulates emotional responses) is disrupted in both depression and anxiety disorders. When this circuit isn’t communicating properly, the emotional brain reacts too strongly and the rational brain can’t rein it in. This creates the conditions for both excessive worry and persistent low mood.
Inflammation as a Common Driver
People with depression consistently show elevated levels of inflammatory markers in their blood, particularly two proteins called TNF-alpha and IL-6. In one study, IL-6 levels in people with major depression were roughly five times higher than in healthy controls. These same inflammatory molecules are elevated in anxiety disorders.
This matters because inflammation doesn’t just affect the body. These proteins cross into the brain and interfere with the production and signaling of neurotransmitters involved in mood regulation. Anti-inflammatory drugs combined with antidepressants have been shown to reduce both inflammatory markers and depressive symptoms, which supports the idea that inflammation isn’t just a side effect of feeling bad. It’s part of what keeps both conditions going.
The Same Thinking Trap Fuels Both
Anxiety and depression feel different from the inside. Anxiety points forward: “What if something terrible happens?” Depression points backward: “Why did everything go wrong?” But researchers have identified that these two mental habits, worry and rumination, are variations of a single process called repetitive negative thinking. It’s the same engine running on different fuel.
Studies using statistical models to tease apart these thinking styles found that the overlap between rumination and worry accounted for 16% of variation in repetitive negative thinking overall. More than half of that shared space (9.8%) was also explained by the overlap between depression and anxiety symptoms. In practical terms, the tendency to get stuck in loops of negative thought is one of the main reasons both conditions persist and reinforce each other. You worry about the future, which exhausts you, which makes you ruminate about your failures, which makes you more anxious about what comes next.
This is one of the clearest examples of how anxiety can slide into depression and vice versa. The thinking pattern doesn’t change much. Only its direction does.
How One Condition Sets the Stage for the Other
A useful framework for understanding the overlap comes from what psychologists call the tripartite model. It proposes that anxiety and depression share a large component of general emotional distress, the kind of nonspecific misery that makes everything feel harder. What differentiates them are two narrower features: physical hyperarousal (racing heart, muscle tension, restlessness) is specific to anxiety, while anhedonia (the inability to feel pleasure or interest) is specific to depression.
This explains something that puzzles many people who experience both conditions. The core suffering feels the same because it largely is the same. The general distress component is doing most of the work. The distinguishing symptoms are just the edges of two heavily overlapping circles. Someone living with chronic general distress is primed to develop both the hyperarousal symptoms of anxiety and the motivational collapse of depression, sometimes simultaneously, sometimes in sequence.
What This Means for Treatment
Because anxiety and depression share so much underlying biology and psychology, treatments that target what they have in common can be effective for both. Transdiagnostic cognitive-behavioral therapy, which focuses on emotional regulation skills rather than disorder-specific techniques, has been tested head-to-head against traditional single-disorder treatments. At three-year follow-up, outcomes and remission rates were comparable between the two approaches. A single treatment framework produced results just as durable as specialized protocols designed for each condition individually.
This makes clinical sense given everything above. If the genetic vulnerability is shared, the stress system disruption is shared, the inflammatory profile is shared, and the thinking patterns are shared, then a treatment that addresses the common core should work for both. Medications that affect serotonin signaling, the most commonly prescribed class of antidepressants, are also first-line treatments for most anxiety disorders. They work for both conditions not by coincidence, but because they’re targeting the same disrupted systems.
For people living with both anxiety and depression, the practical takeaway is that you’re not dealing with two separate problems that happened to show up at the same time. You’re dealing with one vulnerability that expresses itself in two directions. Treating one without acknowledging the other often leaves people partially better but still struggling, which is why integrated approaches tend to produce the most lasting results.